Authored by: Sarah Gantz, Baltimore Business Journal
Baltimore startup Gemstone Biotherapeutics has raised $1.6 million as it races to bring to market a synthetic material for healing wounds.
The financing round was led by founding investor Gamma 3 LLC in Baltimore. The new funding brings Gemstone’s total seed funding to $2.45 million.
Read more at Baltimore Business Journal